{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T14:50:42Z","timestamp":1794408642922,"version":"4.9.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill & Melinda Gates Foundation","doi-asserted-by":"crossref","award":["INV-035751"],"award-info":[{"award-number":["INV-035751"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["U19AI089674"],"award-info":[{"award-number":["U19AI089674"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000061","name":"FOGARTY INTERNATIONAL CENTER","doi-asserted-by":"crossref","award":["U2RTW010672"],"award-info":[{"award-number":["U2RTW010672"]}],"id":[{"id":"10.13039\/100000061","id-type":"DOI","asserted-by":"crossref"}]},{"name":"NIH-NIAID","award":["K24AI144048"],"award-info":[{"award-number":["K24AI144048"]}]},{"name":"NIH-NIAID","award":["K23AI166009"],"award-info":[{"award-number":["K23AI166009"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Malar J"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Histidine Rich Protein 2 (HRP2)\/pan-Lactate Dehydrogenase (pLDH) combination rapid diagnostic tests (RDTs) may address the shortcomings of RDTs that detect HRP2 alone. However, the relative contribution of the possible causes of discordant results (RDT-negative and microscopy-positive) and performance in field settings across Uganda are poorly quantified.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      This study utilized samples from two cross-sectional surveys conducted in 32 districts at 64 sites across Uganda between November 2021 and March 2023 that enrolled 6354 febrile participants \u2009\u2265\u2009two years of age. Discordant samples (negative by HRP2\/pLDH RDT and positive by microscopy) underwent quantitative PCR (qPCR) to detect and quantify parasitaemia. Those confirmed to be positive for\n                      <jats:italic>Plasmodium falciparum<\/jats:italic>\n                      at\u2009&gt;\u20091 parasites\/microlitre (p\/\u00b5L) were tested for\n                      <jats:italic>pfhrp2<\/jats:italic>\n                      and\n                      <jats:italic>pfhrp3<\/jats:italic>\n                      deletions using digital PCR. Those that were negative or had\n                      <jats:italic>P. falciparum<\/jats:italic>\n                      detected at\u2009\u2264\u20091 p\/\u00b5L underwent\n                      <jats:italic>Plasmodium<\/jats:italic>\n                      species testing using nested PCR. The performance of the Bioline Malaria Ag P.f\/Pan combination RDT was evaluated by comparison with microscopy and qPCR.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      There were 166 (8.4%) discordant samples out of 1988 microscopy positive samples. Of these, 90\/166 (54.2%) were confirmed to contain\n                      <jats:italic>P. falciparum<\/jats:italic>\n                      at levels\u2009&gt;\u20091 p\/\u00b5L, whereas 76\/166 (45.8%) were negative or had\n                      <jats:italic>P. falciparum<\/jats:italic>\n                      levels\u2009\u2264\u20091 p\/\u00b5L. Only one\n                      <jats:italic>P. falciparum<\/jats:italic>\n                      positive sample was confirmed to have a deletion in\n                      <jats:italic>pfhrp3<\/jats:italic>\n                      . The primary reasons for RDT-negative, microscopy-positive discordance in samples testing negative for\n                      <jats:italic>P. falciparum<\/jats:italic>\n                      by PCR were non-falciparum species (37\/76, 48.7%) or false positives by microscopy (31\/76, 40.8%). The sensitivity of the Bioline Malaria Ag P.f\/Pan combination RDT was high (&gt;\u200991%) using either microscopy or qPCR as the gold standard. However, specificity was low (56.7%) when microscopy was used as the gold standard; it improved to 64.0% when qPCR was used as the gold standard.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      The Bioline Malaria Ag P.f\/Pan combination RDT was found to be highly sensitive in Uganda and reliable for ruling out malaria. False negative RDT results were primarily due to low density\n                      <jats:italic>P. falciparum<\/jats:italic>\n                      infections, non-falciparum infections, or incorrect microscopy results. In contrast, false positive RDT results were common, most likely due to persistent HRP2 antigenaemia in this high transmission setting though causes of false positive RDTs were not investigated. The low specificity of HRP2-based RDTs may result in overuse of anti-malarial drugs and missed diagnoses of non-malarial febrile illnesses.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12936-025-05379-6","type":"journal-article","created":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T05:43:40Z","timestamp":1746078220000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Field evaluation of the Bioline Malaria Ag P.f\/Pan rapid diagnostic test: causes of microscopy discordance and performance in Uganda"],"prefix":"10.1186","volume":"24","author":[{"given":"Kisakye Diana","family":"Kabbale","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bienvenu","family":"Nsengimaana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis D.","family":"Semakuba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian A.","family":"Kagurusi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Mwubaha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Innocent","family":"Wiringilimaana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Katairo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahiid","family":"Kiyaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Mbabazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Gonahasa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moses R.","family":"Kamya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Tukwasibwe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sam L.","family":"Nsobya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Asua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daudi","family":"Jjingo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bosco","family":"Agaba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Maiteki-Sebuguzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jimmy","family":"Opigo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kylie","family":"Hilton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah G.","family":"Staedke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grant","family":"Dorsey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa D.","family":"Conrad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan","family":"Greenhouse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isaac","family":"Ssewanyana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Briggs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,1]]},"reference":[{"key":"5379_CR1","volume-title":"World malaria report 2023","author":"WHO","year":"2023","unstructured":"WHO. World malaria report 2023. Geneva: World Health Organization; 2023."},{"key":"5379_CR2","unstructured":"National Malaria Control Division, Uganda Bureau of Statistics, ICF. Malaria Indicator Survey 2018\u20132019. Kampala, Uganda and Rockville, Maryland, USA. 2020."},{"key":"5379_CR3","unstructured":"National Malaria Control Division, Ministry of Health. The Uganda Malaria Reduction Strategic Plan 2014\u20132020. Kampala, Uganda. 2014."},{"key":"5379_CR4","volume-title":"Guidelines for malaria, 2023","author":"WHO","year":"2023","unstructured":"WHO. Guidelines for malaria, 2023. Geneva: World Health Organization; 2023."},{"key":"5379_CR5","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1128\/CMR.15.1.66-78.2002","volume":"15","author":"A Moody","year":"2002","unstructured":"Moody A. Rapid diagnostic tests for malaria parasites. Clin Microbiol Rev. 2002;15:66\u201378.","journal-title":"Clin Microbiol Rev"},{"key":"5379_CR6","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1186\/s12936-021-03739-6","volume":"20","author":"A Kong","year":"2021","unstructured":"Kong A, Wilson SA, Ah Y, Nace D, Rogier E, Aidoo M. HRP2 and HRP3 cross-reactivity and implications for HRP2-based RDT use in regions with Plasmodium falciparum hrp2 gene deletions. Malar J. 2021;20:207.","journal-title":"Malar J"},{"key":"5379_CR7","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1086\/526502","volume":"197","author":"H Hopkins","year":"2008","unstructured":"Hopkins H, Bebell L, Kambale W, Dokomajilar C, Rosenthal PJ, Dorsey G. Rapid diagnostic tests for malaria at sites of varying transmission intensity in Uganda. J Infect Dis. 2008;197:510\u20138.","journal-title":"J Infect Dis"},{"key":"5379_CR8","volume-title":"Malaria rapid diagnostic test performance. Results of WHO product testing of malaria RDTs Round 8 (2016\u20132018)","author":"WHO","year":"2018","unstructured":"WHO. Malaria rapid diagnostic test performance. Results of WHO product testing of malaria RDTs Round 8 (2016\u20132018). Geneva: World Health Organization; 2018."},{"key":"5379_CR9","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s12936-023-04830-w","volume":"23","author":"BB Agaba","year":"2024","unstructured":"Agaba BB, Smith D, Travis J, Pasay C, Nabatanzi M, Arinaitwe E, et al. Limited threat of Plasmodium falciparum pfhrp2 and pfhrp3 gene deletion to the utility of HRP2-based malaria RDTs in Northern Uganda. Malar J. 2024;23:3.","journal-title":"Malar J"},{"key":"5379_CR10","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s12936-020-03547-4","volume":"20","author":"SL Nsobya","year":"2021","unstructured":"Nsobya SL, Walakira A, Namirembe E, Kiggundu M, Nankabirwa JI, Ruhamyankaka E, et al. Deletions of pfhrp2 and pfhrp3 genes were uncommon in rapid diagnostic test-negative Plasmodium falciparum isolates from Uganda. Malar J. 2021;20:4.","journal-title":"Malar J"},{"key":"5379_CR11","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.4269\/ajtmh.2007.76.1092","volume":"76","author":"H Hopkins","year":"2007","unstructured":"Hopkins H, Kambale W, Kamya MR, Staedke SG, Dorsey G, Rosenthal PJ. Comparison of HRP2- and pLDH-based rapid diagnostic tests for malaria with longitudinal follow-up in Kampala, Uganda. Am J Trop Med Hyg. 2007;76:1092\u20137.","journal-title":"Am J Trop Med Hyg"},{"key":"5379_CR12","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/1475-2875-13-43","volume":"13","author":"M Hawkes","year":"2014","unstructured":"Hawkes M, Conroy AL, Opoka RO, Namasopo S, Liles WC, John CC, et al. Use of a three-band HRP2\/pLDH combination rapid diagnostic test increases diagnostic specificity for falciparum malaria in Ugandan children. Malar J. 2014;13:43.","journal-title":"Malar J"},{"key":"5379_CR13","doi-asserted-by":"publisher","first-page":"956","DOI":"10.4269\/ajtmh.24-0003","volume":"111","author":"A Golden","year":"2024","unstructured":"Golden A, Slater HC, Jang IK, Walke S, Phan TT, Bizilj GT, et al. Analytical sensitivity analysis and clinical impact modeling of rapigen rapid diagnostic tests for malaria. Am J Trop Med Hyg. 2024;111:956\u201366.","journal-title":"Am J Trop Med Hyg"},{"key":"5379_CR14","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.4269\/ajtmh.18-1013","volume":"100","author":"RK Mehlotra","year":"2019","unstructured":"Mehlotra RK, Howes RE, Cramer EY, Tedrow RE, Rakotomanga TA, Ramboarina S, et al. Plasmodium falciparum parasitemia and band sensitivity of the SD Bioline Malaria Ag Pf\/Pan rapid diagnostic test in Madagascar. Am J Trop Med Hyg. 2019;100:1196\u2013201.","journal-title":"Am J Trop Med Hyg"},{"key":"5379_CR15","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1186\/s12936-024-05023-9","volume":"23","author":"M Ranjbar","year":"2024","unstructured":"Ranjbar M, Tegegn WY. Non-falciparum malaria infections in Uganda, does it matter? A review of the published literature. Malar J. 2024;23:207.","journal-title":"Malar J"},{"key":"5379_CR16","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.25008","volume":"6","author":"OJ Watson","year":"2017","unstructured":"Watson OJ, Slater HC, Verity R, Parr JB, Mwandagalirwa MK, Tshefu A, et al. Modelling the drivers of the spread of Plasmodium falciparum hrp2 gene deletions in sub-Saharan Africa. ELife. 2017;6: e25008.","journal-title":"ELife"},{"key":"5379_CR17","doi-asserted-by":"crossref","unstructured":"Gonahasa S, Namuganga JF, Nassali MJ, Maiteki-Sebuguzi C, Nabende I, Epstein A, et al. LLIN Evaluation in Uganda Project (LLINEUP2) \u2013 Effect of long-lasting insecticidal nets (LLINs) treated with pyrethroid plus pyriproxyfen vs LLINs treated with pyrethroid plus piperonyl butoxide in Uganda: a cluster-randomised trial. medRxiv; 2024.","DOI":"10.1101\/2024.07.31.24311272"},{"key":"5379_CR18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001788","volume":"12","author":"N Hofmann","year":"2015","unstructured":"Hofmann N, Mwingira F, Shekalaghe S, Robinson LJ, Mueller I, Felger I. Ultra-sensitive detection of Plasmodium falciparum by amplification of multi-copy subtelomeric targets. PLoS Med. 2015;12: e1001788.","journal-title":"PLoS Med"},{"key":"5379_CR19","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/s12936-021-03630-4","volume":"20","author":"NB Teyssier","year":"2021","unstructured":"Teyssier NB, Chen A, Duarte EM, Sit R, Greenhouse B, Tessema SK. Optimization of whole-genome sequencing of Plasmodium falciparum from low-density dried blood spot samples. Malar J. 2021;20:116.","journal-title":"Malar J"},{"key":"5379_CR20","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/0166-6851(93)90077-B","volume":"61","author":"G Snounou","year":"1993","unstructured":"Snounou G, Viriyakosol S, Zhu XP, Jarra W, Pinheiro L, do Rosario VE, et al. High sensitivity of detection of human malaria parasites by the use of nested polymerase chain reaction. Mol Biochem Parasitol. 1993;61:315\u201320.","journal-title":"Mol Biochem Parasitol"},{"key":"5379_CR21","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.72083","volume":"11","author":"CA Vera-Arias","year":"2022","unstructured":"Vera-Arias CA, Holzschuh A, Oduma CO, Badu K, Abdul-Hakim M, Yukich J, et al. High-throughput Plasmodium falciparum hrp2 and hrp3 gene deletion typing by digital PCR to monitor malaria rapid diagnostic test efficacy. ELife. 2022;11: e72083.","journal-title":"ELife"},{"key":"5379_CR22","unstructured":"QGIS Development Team. QGIS Geographic Information System. QGIS Association. 2021. http:\/\/www.qgis.org"},{"key":"5379_CR23","unstructured":"R Core Team. R: A Language and Environment for Statistical Computing 2023. https:\/\/www.R-project.org\/"},{"key":"5379_CR24","unstructured":"Stevenson M. epiR: tools for analysis of epidemiological data 2024. (https:\/\/cran.r-project.org\/web\/packages\/epiR\/index.html)"},{"key":"5379_CR25","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1186\/s12936-020-03459-3","volume":"19","author":"C Bakari","year":"2020","unstructured":"Bakari C, Jones S, Subramaniam G, Mandara CI, Chiduo MG, Rumisha S, et al. Community-based surveys for Plasmodium falciparum pfhrp2 and pfhrp3 gene deletions in selected regions of mainland Tanzania. Malar J. 2020;19:391.","journal-title":"Malar J"},{"key":"5379_CR26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0244457","volume":"15","author":"AB Bosco","year":"2020","unstructured":"Bosco AB, Nankabirwa JI, Yeka A, Nsobya S, Gresty K, Anderson K, et al. Limitations of rapid diagnostic tests in malaria surveys in areas with varied transmission intensity in Uganda 2017\u20132019: implications for selection and use of HRP2 RDTs. PLoS ONE. 2020;15: e0244457.","journal-title":"PLoS ONE"},{"key":"5379_CR27","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1186\/1475-2875-13-308","volume":"13","author":"G Ilombe","year":"2014","unstructured":"Ilombe G, Maketa V, Mavoko HM, da Luz RI, Lutumba P, Van geertruyden J-P. Performance of HRP2-based rapid test in children attending the health centre compared to asymptomatic children in the community. Malar J. 2014;13:308.","journal-title":"Malar J"},{"key":"5379_CR28","doi-asserted-by":"publisher","first-page":"1083114","DOI":"10.3389\/fepid.2023.1083114","volume":"3","author":"D Okanda","year":"2023","unstructured":"Okanda D, Ndwiga L, Osoti V, Achieng N, Wambua J, Ngetsa C, et al. Low frequency of Plasmodium falciparum hrp2\/3 deletions from symptomatic infections at a primary healthcare facility in Kilifi Kenya. Front Epidemiol. 2023;3:1083114.","journal-title":"Front Epidemiol"},{"key":"5379_CR29","doi-asserted-by":"publisher","first-page":"6495","DOI":"10.1038\/s41598-021-85913-z","volume":"11","author":"JB Parr","year":"2021","unstructured":"Parr JB, Kieto E, Phanzu F, Mansiangi P, Mwandagalirwa K, Mvuama N, et al. Analysis of false-negative rapid diagnostic tests for symptomatic malaria in the Democratic Republic of the Congo. Sci Rep. 2021;11:6495.","journal-title":"Sci Rep"},{"key":"5379_CR30","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1046\/j.1365-2257.2000.00318.x","volume":"22","author":"AH Moody","year":"2000","unstructured":"Moody AH, Chiodini PL. Methods for the detection of blood parasites. Clin Lab Haematol. 2000;22:189\u2013201.","journal-title":"Clin Lab Haematol"},{"key":"5379_CR31","volume-title":"Malaria microscopy quality assurance manual Version 2","author":"WHO","year":"2016","unstructured":"WHO. Malaria microscopy quality assurance manual Version 2. Geneva: World Health Organization; 2016."},{"key":"5379_CR32","doi-asserted-by":"publisher","first-page":"778","DOI":"10.4269\/ajtmh.19-0653","volume":"103","author":"TJ Owalla","year":"2020","unstructured":"Owalla TJ, Okurut E, Apungia G, Ojakol B, Lema J, Murphy S, et al. Using the ultrasensitive Alere Plasmodium falciparum malaria Ag HRP-2TM rapid diagnostic test in the field and clinic in Northeastern Uganda. Am J Trop Med Hyg. 2020;103:778\u201384.","journal-title":"Am J Trop Med Hyg."},{"key":"5379_CR33","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1186\/1475-2875-11-204","volume":"11","author":"M Heutmekers","year":"2012","unstructured":"Heutmekers M, Gillet P, Maltha J, Scheirlinck A, Cnops L, Bottieau E, et al. Evaluation of the rapid diagnostic test CareStart pLDH Malaria (Pf-pLDH\/pan-pLDH) for the diagnosis of malaria in a reference setting. Malar J. 2012;11:204.","journal-title":"Malar J"},{"key":"5379_CR34","volume-title":"Surveillance template protocol for pfhrp2\/pfhrp3 gene deletions","author":"WHO","year":"2020","unstructured":"WHO. Surveillance template protocol for pfhrp2\/pfhrp3 gene deletions. Geneva: World Health Organization; 2020."},{"key":"5379_CR35","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1186\/s12936-020-03362-x","volume":"19","author":"AB Bosco","year":"2020","unstructured":"Bosco AB, Anderson K, Gresty K, Prosser C, Smith D, Nankabirwa JI, et al. Molecular surveillance reveals the presence of pfhrp2 and pfhrp3 gene deletions in Plasmodium falciparum parasite populations in Uganda, 2017\u20132019. Malar J. 2020;19:300.","journal-title":"Malar J"},{"key":"5379_CR36","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1093\/infdis\/jiz335","volume":"220","author":"R Thomson","year":"2019","unstructured":"Thomson R, Beshir KB, Cunningham J, Baiden F, Bharmal J, Bruxvoort KJ, et al. pfhrp2 and pfhrp3 gene deletions that affect malaria rapid diagnostic tests for Plasmodium falciparum: analysis of archived blood samples from 3 African Countries. J Infect Dis. 2019;220:1444\u201352.","journal-title":"J Infect Dis"},{"key":"5379_CR37","doi-asserted-by":"publisher","first-page":"8158","DOI":"10.1038\/s41598-024-58455-3","volume":"14","author":"E Rogier","year":"2024","unstructured":"Rogier E, Ishengoma DS. Plasmodium falciparum pfhrp2 and pfhrp3 gene deletions among patients enrolled at 100 health facilities throughout Tanzania: february to July 2021. Sci Rep. 2024;14:8158.","journal-title":"Sci Rep"},{"key":"5379_CR38","doi-asserted-by":"publisher","first-page":"14718","DOI":"10.1038\/s41598-017-15031-2","volume":"7","author":"KB Beshir","year":"2017","unstructured":"Beshir KB, Sep\u00falveda N, Bharmal J, Robinson A, Mwanguzi J, Busula AO, et al. Plasmodium falciparum parasites with histidine-rich protein 2 (pfhrp2) and pfhrp3 gene deletions in two endemic regions of Kenya. Sci Rep. 2017;7:14718.","journal-title":"Sci Rep"},{"key":"5379_CR39","doi-asserted-by":"publisher","first-page":"462","DOI":"10.3201\/eid2403.171723","volume":"24","author":"A Berhane","year":"2018","unstructured":"Berhane A, Anderson KF, Mihreteab S, Gresty K, Rogier E, Mohamed S, et al. Major threat to malaria control programs by Plasmodium falciparum lacking histidine-rich protein 2. Eritrea Emerg Infect Dis. 2018;24:462\u201370.","journal-title":"Eritrea Emerg Infect Dis"},{"key":"5379_CR40","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0008091","volume":"5","author":"D Gamboa","year":"2010","unstructured":"Gamboa D, Ho M-F, Bendezu J, Torres K, Chiodini PL, Barnwell JW, et al. A Large proportion of P falciparum isolates in the Amazon Region of Peru lack pfhrp2 and pfhrp3 implications for malaria rapid diagnostic tests. PLoS One. 2010;5: e8091.","journal-title":"PLoS One"},{"key":"5379_CR41","unstructured":"Global Fund. Pooled Procurement Mechanism Reference Pricing: RDTs."},{"key":"5379_CR42","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1186\/s12936-022-04226-2","volume":"21","author":"KB Beshir","year":"2022","unstructured":"Beshir KB, Parr JB, Cunningham J, Cheng Q, Rogier E. Screening strategies and laboratory assays to support Plasmodium falciparum histidine-rich protein deletion surveillance: where we are and what is needed. Malar J. 2022;21:201.","journal-title":"Malar J"},{"key":"5379_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2020.102757","volume":"55","author":"L Grignard","year":"2020","unstructured":"Grignard L, Nolder D, Sep\u00falveda N, Berhane A, Mihreteab S, Kaaya R, et al. A novel multiplex qPCR assay for detection of Plasmodium falciparum with histidine-rich protein 2 and 3 (pfhrp2 and pfhrp3) deletions in polyclonal infections. EBioMedicine. 2020;55: 102757.","journal-title":"EBioMedicine"},{"key":"5379_CR44","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0203524","volume":"13","author":"D Adu-Gyasi","year":"2018","unstructured":"Adu-Gyasi D, Asante KP, Amoako S, Amoako N, Ankrah L, Dosoo D, et al. Assessing the performance of only HRP2 and HRP2 with pLDH based rapid diagnostic tests for the diagnosis of malaria in middle Ghana. Africa PLoS One. 2018;13: e0203524.","journal-title":"Africa PLoS One"},{"key":"5379_CR45","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1186\/s12936-017-1980-z","volume":"16","author":"MA Diallo","year":"2017","unstructured":"Diallo MA, Diongue K, Ndiaye M, Gaye A, Deme A, Badiane AS, et al. Evaluation of CareStart\u2122 Malaria HRP2\/pLDH (Pf\/pan) Combo Test in a malaria low transmission region of Senegal. Malar J. 2017;16:328.","journal-title":"Malar J"},{"key":"5379_CR46","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1128\/JCM.00130-17","volume":"55","author":"M Murungi","year":"2017","unstructured":"Murungi M, Fulton T, Reyes R, Matte M, Ntaro M, Mulogo E, et al. Improving the specificity of Plasmodium falciparum malaria diagnosis in high-transmission settings with a two-step rapid diagnostic test and microscopy algorithm. J Clin Microbiol. 2017;55:1540\u20139.","journal-title":"J Clin Microbiol"},{"key":"5379_CR47","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.actatropica.2012.10.002","volume":"125","author":"R Tahar","year":"2013","unstructured":"Tahar R, Sayang C, Ngane Foumane V, Soula G, Moyou-Somo R, Delmont J, et al. Field evaluation of rapid diagnostic tests for malaria in Yaounde. Cameroon Acta Trop. 2013;125:214\u20139.","journal-title":"Cameroon Acta Trop"},{"key":"5379_CR48","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1186\/1475-2875-7-221","volume":"7","author":"DJ Kyabayinze","year":"2008","unstructured":"Kyabayinze DJ, Tibenderana JK, Odong GW, Rwakimari JB, Counihan H. Operational accuracy and comparative persistent antigenicity of HRP2 rapid diagnostic tests for Plasmodium falciparum malaria in a hyperendemic region of Uganda. Malar J. 2008;7:221.","journal-title":"Malar J"},{"key":"5379_CR49","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008122.pub2","author":"K Abba","year":"2011","unstructured":"Abba K, Deeks JJ, Olliaro PL, Naing C, Jackson SM, Takwoingi Y, et al. Rapid diagnostic tests for diagnosing uncomplicated P falciparum malaria in endemic countries. Cochrane Database Syst Rev. 2011. https:\/\/doi.org\/10.1002\/14651858.CD008122.pub2.","journal-title":"Cochrane Database Syst Rev"},{"key":"5379_CR50","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1186\/1475-2875-7-202","volume":"7","author":"TA Abeku","year":"2008","unstructured":"Abeku TA, Kristan M, Jones C, Beard J, Mueller DH, Okia M, et al. Determinants of the accuracy of rapid diagnostic tests in malaria case management: evidence from low and moderate transmission settings in the East African highlands. Malar J. 2008;7:202.","journal-title":"Malar J"},{"key":"5379_CR51","doi-asserted-by":"publisher","first-page":"440","DOI":"10.3390\/tropicalmed7120440","volume":"7","author":"A Bonko","year":"2022","unstructured":"Bonko A, Tahita MC, Kiemde F, Lompo P, Mens PF, Tinto H, et al. Diagnostic performance of Plasmodium falciparum histidine-rich protein-2 antigen-specific rapid diagnostic test in children at the peripheral health care level in Nanoro (Burkina Faso). Trop Med Infect Dis. 2022;7:440.","journal-title":"Trop Med Infect Dis"},{"key":"5379_CR52","doi-asserted-by":"publisher","first-page":"530","DOI":"10.4269\/ajtmh.14-0180","volume":"92","author":"P Mbabazi","year":"2015","unstructured":"Mbabazi P, Hopkins H, Osilo E, Kalungu M, Byakika-Kibwika P, Kamya MR. Accuracy of two malaria rapid diagnostic tests (RDTS) for initial diagnosis and treatment monitoring in a high transmission setting in Uganda. Am J Trop Med Hyg. 2015;92:530\u20136.","journal-title":"Am J Trop Med Hyg"},{"key":"5379_CR53","doi-asserted-by":"publisher","first-page":"265","DOI":"10.3390\/tropicalmed7100265","volume":"7","author":"X Marti\u00e1\u00f1ez-Vendrell","year":"2022","unstructured":"Marti\u00e1\u00f1ez-Vendrell X, Skjefte M, Sikka R, Gupta H. Factors affecting the performance of HRP2-based malaria rapid diagnostic tests. Trop Med Infect Dis. 2022;7:265.","journal-title":"Trop Med Infect Dis"},{"issue":"Suppl 5","key":"5379_CR54","doi-asserted-by":"publisher","first-page":"S290","DOI":"10.1093\/cid\/ciw628","volume":"63","author":"CO Falade","year":"2016","unstructured":"Falade CO, Ajayi IO, Nsungwa-Sabiiti J, Siribi\u00e9 M, Diarra A, Serm\u00e9 L, et al. Malaria rapid diagnostic tests and malaria microscopy for guiding malaria treatment of uncomplicated fevers in Nigeria and prereferral cases in 3 African Countries. Clin Infect Dis. 2016;63(Suppl 5):S290\u20137.","journal-title":"Clin Infect Dis"},{"key":"5379_CR55","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1093\/cid\/cix592","volume":"65","author":"R Boyce","year":"2017","unstructured":"Boyce R, Reyes R, Matte M, Ntaro M, Mulogo E, Siedner MJ. Use of a dual-antigen rapid diagnostic test to screen children for severe Plasmodium falciparum malaria in a high-transmission, resource-limited setting. Clin Infect Dis. 2017;65:1509\u201315.","journal-title":"Clin Infect Dis"}],"container-title":["Malaria Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-025-05379-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12936-025-05379-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-025-05379-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T07:03:00Z","timestamp":1746082980000},"score":1,"resource":{"primary":{"URL":"https:\/\/malariajournal.biomedcentral.com\/articles\/10.1186\/s12936-025-05379-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,1]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5379"],"URL":"https:\/\/doi.org\/10.1186\/s12936-025-05379-6","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-5629938\/v1","asserted-by":"object"}]},"ISSN":["1475-2875"],"issn-type":[{"value":"1475-2875","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,1]]},"assertion":[{"value":"12 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Makerere University School of Medicine Research and Ethics committee (2020\u2013193), the Uganda National Council of Science and Technology (HS1097ES), University of California, San Francisco, Committee for Human Research (20\u201331769) and the London School of Hygiene and Tropical Medicine Ethics Committee (22615). Written informed consents (with assent from minors) were obtained from all study participants before enrollment.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"138"}}